Skip to content

Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes

Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06028139
Enrollment
400
Registered
2023-09-08
Start date
2023-10-24
Completion date
2024-12-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

Lifestyle change is key to diabetes management but there are limited resources and time to support patients in improving lifestyle behaviour in the current healthcare system. Currently, health coaching for behavioural chance guided by continuous glucose data, wearable and lifestyle data is not available in primary and tertiary care management of diabetes. This parallel-group randomised controlled trial (RCT) aims to investigate the effectiveness of a novel multi-component model of care comprising interventions including the mobile app EMPOWER and smartwatch, health coaching, and continuous glucose monitoring (CGM).

Interventions

BEHAVIORALContinuous glucose monitoring and health coaching

Each CGM device will work for 14 days. The participants will use the CGM devices for the first two-week period in the first three months of the trial, and the first two-week period of the second three months of the trial. Participants will interact with health coach throughout the study duration.

BEHAVIORALEMPOWER mobile app

Nudges will be delivered through the EMPOWER mobile app. Participants will log lifestyle information such as diet and physical activity, and clinical information such as medication and HbA1c levels through the EMPOWER mobile app.

Sponsors

Sengkang General Hospital
CollaboratorOTHER
National Heart Centre Singapore
CollaboratorOTHER
Singapore General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Aged 21 years and above * Have diagnosis of type 2 diabetes mellitus * Provided informed consent * Have near-field communication (NFC) compatible phones * Able to engage in light physical activity (e.g., walking)

Exclusion criteria

* Significant cognitive impairment * Other conditions that may preclude participants from wearing CGM devices

Design outcomes

Primary

MeasureTime frameDescription
HbA1c6 monthsHbA1c over 6 months

Secondary

MeasureTime frameDescription
Physical activity as measured by moderate to vigorous active minutes6 monthsPhysical activity over 6 months
Physical activity as measured by GPAQ6 monthsPhysical activity over 6 months
Diet as measured by DASH6 monthsDiet quality over 6 months
Sugar sweetened beverages intake6 monthsSugar sweetened beverages intake over 6 months
Physical activity as measured by number of steps6 monthsPhysical activity over 6 months
Medication adherence as measured by DOSE-Nonadherence scale6 monthsDifference in medication adherence between intervention and control over 6 months
Quality of life as measured by EQ-5D-5L6 monthsDifference in quality of life between intervention and control over 6 months
Healthcare cost as measured by cost of consultations, lab tests, medications, admission6 monthsHealthcare cost over 6 months
Healthcare cost as measured by WPAI6 monthsHealthcare cost over 6 months
Patient activation score as measured by patient activation measure6 monthsDifference in patient activation score between intervention and control over 6 months

Countries

Singapore

Contacts

Primary ContactLian Leng Low
low.lian.leng@singhealth.com.sg63265872

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026